🇩🇪 Germany Country × Condition
non small cell lung cancer Clinical Trials in Germany
Active clinical trials for non small cell lung cancer with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇩🇪 Germany
Active Trials in Germany (3)
NCT06303505 Phase 1, Phase 2
Recruiting
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Enrollment
250 pts
Country
🇩🇪 Germany
Tubulis GmbH
View Trial → NCT05059444
Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Enrollment
2,020 pts
Country
🇩🇪 Germany
Guardant Health, Inc.
View Trial → NCT05363319
Recruiting
An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe
Enrollment
500 pts
Country
🇩🇪 Germany
Regeneron Pharmaceuticals
View Trial → Frequently Asked Questions
How many non small cell lung cancer clinical trials are active in Germany?
There are currently 3 active clinical trials for non small cell lung cancer with sites in Germany, of which 3 are actively recruiting patients.
How can I join a non small cell lung cancer clinical trial in Germany?
To join a non small cell lung cancer clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are non small cell lung cancer trials in Germany?
Active non small cell lung cancer trials in Germany span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology